Furthermore, antioestrogens (e.g. Tamoxifen) of particular affinity for the specific splice variant of oestrogen receptor expressed by each individual breast carcinoma may have agonistic effects in ERβ-positive tumours, hence resulting in a lack of efficacy of hormonal therapy (Speirs et al, 1999). This evidence concerns the gene ESR2 and neoplasm.